DANBURY, CT--(Marketwired - April 06, 2015) - Biodel Inc. (BIOD) announced results from a formative human factors study of its Glucagon Emergency Management (GEM) device, which is in development for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results